DNA microsatellite genotyping of potentially pathogenic Candida albicans and C. dubliniensis isolated from the oral cavity and dental prostheses

Microb Pathog. 2020 Dec:149:104548. doi: 10.1016/j.micpath.2020.104548. Epub 2020 Oct 12.

Abstract

This study investigated the incidence, genetic diversity, antifungal sensitivity, and virulence of Candida albicans and C. dubliniensis isolated from subjects using dental prostheses and subjects clinically indicated for the first prosthetic rehabilitation. Subjects were divided into four groups and samples were collected twice: at first rehabilitation by removable partial (A) and total (C) dental prostheses, and replacement of the removable partial (B) and total (D) prostheses. Yeasts were genotyped using DNA microsatellite markers. Microbiological methods were used to screen for azole antifungal resistance and exoenzyme production. In the initial sampling, oral colonization by Candida was observed in 31 (53.4%) subjects in groups A (33.3%), B (68.2%), and D (65%); 20 (47.6%) subjects displayed colonization of prostheses: groups B (50%) and D (45%). The second sampling (±30 days) revealed Candida in 2 (3.4%: oral cavity) and 4 (6.9%: prosthetic) subjects from group B. C. albicans and C. dubliniensis displayed both polyclonal and monoclonal patterns of infection. Azole-resistant C. albicans and SAPs+ strains were prevalent. Related strains were found in one or several oral sites (mucosa and prosthesis), as well as intra- and inter-subject, -gender, -group, and -time of sampling. However, the patterns of clonality can be altered under dental care.

Keywords: Antifungal resistance; C. albicans; Candida species; DNA microsatellites; Dental prostheses; Secreted aspartyl proteinases and phospholipases.

MeSH terms

  • Antifungal Agents / pharmacology
  • Candida / genetics
  • Candida albicans* / genetics
  • DNA
  • Dental Prosthesis*
  • Genotype
  • Humans
  • Microsatellite Repeats
  • Mouth

Substances

  • Antifungal Agents
  • DNA